Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Luca Benatti Insider Profile
4 Followers
Luca Benatti, Director at Newron Pharmaceuticals SpA, holds ― shares in Newron Pharmaceuticals SpA (Ticker: NWPHF). Most recently, Luca Benatti Sold $10,382 shares of Newron Pharmaceuticals SpA on May 22, 2024 for an estimated value of 108.68K.
Luca Benatti has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Luca Benatti does not currently own shares as a corporate insider.
A breakdown of Luca Benatti's holdings
Insider Roles
Director
Roles that Luca Benatti holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Luca Benatti
Luca Benatti's Trading History
List of latest transactions for each holding click on a transaction to see Luca Benatti's performance on stock
You May Also Like
Luca Benatti insider profile FAQ
What is the percentage of profitable transactions made by Luca Benatti?
The percentage of profitable transactions made by Luca Benatti is ―.
What is the average return per transaction made by Luca Benatti?
The average return per transaction made by Luca Benatti is ―.
What stocks does Luca Benatti hold?
Luca Benatti holds: NWPHF stocks.
What was Luca Benatti’s latest transaction?
Luca Benatti latest transaction was an Informative Sell of $108.68K.
What was Luca Benatti's most profitable transaction?
Luca Benatti’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Luca Benatti's role in Newron Pharmaceuticals SpA?
Luca Benatti's role in Newron Pharmaceuticals SpA is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.